This commercial-stage biotechnology company developing next-generation, targeted antibody drug conjugates is aiming to achieve double-digit year-over-year revenue growth for its lead drug.
The human brain, which weighs about 3 pounds and contains billions of neurons, is considered the most complex structure in the universe. Stroke, epilepsy, psychiatric disorders such as depression, schizophrenia, and anxiety disorders, and neurodegenerative brain diseases like Alzheimer's, Parkinson's, neurodevelopmental disorders are some of the diseases and disorders affecting the brain.
Nkarta Inc. (NKTX) is scheduled to report updated clinical data from its ongoing clinical trial of NKX019, its CD19-directed CAR NK cell therapy candidate, today, December 5.